MODERN APPROACHES TO THE USE OF MUCOLYTIC AND BRONCHODILATOR AGENTS IN ACUTE RESPIRATORY VIRAL INFECTIONS WITH BRONCHIAL OBSTRUCTION IN CHILDREN

In children with acute respiratory viral infections, the lower respiratory tract is often involved, leading to the development of bronchial obstruction. The use of the combined preparation Ascoril Expectorant (bromhexine + salbutamol + guaifenesin), due to its combined bronchodilator and mucolytic effects, results in rapid regression of disease symptoms, prevents progression to a more severe and prolonged course, and subsequently reduces the need for antibiotic therapy. The clinical efficacy and favorable safety profile of Ascoril Expectorant allow it to be recommended as the drug of choice for children over 2 years of age with mild to moderate bronchial obstruction associated with ARVI.